The pneumothorax treatment devices market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.39 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in traumatic chest injuries, increased road accident cases, hospital emergency infrastructure growth, adoption of chest tube procedures, critical care unit expansion.
The pneumothorax treatment devices market size is expected to see rapid growth in the next few years. It will grow to $6.43 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to growth in portable emergency devices, advancements in thoracic vent systems, increased ICU admissions, demand for faster lung re-expansion, emergency medical service expansion. Major trends in the forecast period include rapid emergency lung decompression, portable pneumothorax management devices, minimally invasive chest drainage, improved air leak control systems, simplified bedside treatment kits.
The rising number of respiratory diseases is anticipated to drive the growth of the pneumothorax treatment devices market. Respiratory diseases are conditions that affect the lungs and airways, leading to impaired breathing and reduced oxygen exchange. The increase in respiratory diseases is attributed to factors such as air pollution, smoking, viral infections, and greater exposure to allergens. Pneumothorax treatment devices are used in the management of respiratory conditions to treat collapsed lungs and restore normal respiratory function. For example, in September 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, deaths involving influenza rose from 611 in 2023 to 806 in 2024 and further increased to 1,057 deaths in the year to August 2025, representing a 73% rise compared with the same period in 2023. Additionally, deaths involving respiratory syncytial virus (RSV) increased from 380 in 2023 to 468 in 2024 and reached 399 deaths in the year to August 2025. Therefore, the growing incidence of respiratory diseases is driving the expansion of the pneumothorax treatment devices market.
Leading companies in the pneumothorax treatment devices market are focusing on developing advanced technological solutions, such as chest X-ray systems, to maintain their market position. Chest X-ray solutions involve imaging systems and technologies designed to capture detailed radiographic images of the chest, including the lungs, heart, ribs, and surrounding structures. For instance, in September 2023, Qure.ai, a US-based health tech company, announced that it received 510(k) FDA clearance for its innovative chest X-ray solution, qXR-PTX-PE. This solution is specifically designed to aid in the rapid detection of pneumothorax (PTX) and pleural effusion (PE). The AI-powered software enhances care in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare providers. The qXR-PTX-PE solution analyzes chest X-ray images for critical findings, significantly improving triage efficiency in emergency settings, where these conditions can pose serious risks to patient health.
In June 2023, Merit Medical Systems, Inc., a US-based medical technology company specializing in interventional, diagnostic, and critical care products, acquired AngioDynamics, Inc., for US$100 million in cash. Through this acquisition, Merit Medical aims to reinforce and expand its interventional oncology and lung biopsy-related complication management portfolio by incorporating the BioSentry system, which is designed to reduce the incidence of biopsy-related pneumothorax. This move is intended to strengthen Merit Medical’s position in the global pneumothorax treatment devices market while also broadening its offerings in vascular access and dialysis care. AngioDynamics, Inc. is a US-based medical device company focused on minimally invasive vascular, oncology, and biopsy-related products.
Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc.
North America was the largest region in the pneumothorax treatment devices market in 2025. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pneumothorax treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pneumothorax treatment devices market by increasing costs of imported ventilator components, chest drainage systems, and disposable kits. Ventilator devices and thoracic vent segments are most affected, particularly in North America and Europe due to reliance on Asia-Pacific manufacturing. While tariffs have raised procurement costs, they have also encouraged local manufacturing, simplified device designs, and regional sourcing strategies.
The pneumothorax treatment devices market research report is one of a series of new reports that provides pneumothorax treatment devices market statistics, including pneumothorax treatment devices industry global market size, regional shares, competitors with a pneumothorax treatment devices market share, detailed pneumothorax treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the pneumothorax treatment devices industry. This pneumothorax treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pneumothorax treatment devices are medical tools used to manage and treat a collapsed lung, a condition in which air accumulates in the pleural space. These devices aim to remove excess air, restore lung expansion, and prevent further complications, often through methods such as needle decompression or chest tube insertion.
The primary types of pneumothorax treatment devices include ventilator devices, thoracic vent devices, and others. Ventilator devices used in pneumothorax treatment help assist or control breathing by delivering air to the lungs, thereby maintaining oxygen levels and preventing further lung collapse during recovery. These devices are employed in various situations, such as traumatic pneumothorax, spontaneous pneumothorax, and others, in settings such as hospitals, ambulatory surgical centers, and other medical facilities.
The pneumothorax treatment devices market consists of sales of products including tubes, valves, suction devices and systems, and digital thoracic drainage systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pneumothorax treatment devices market size is expected to see rapid growth in the next few years. It will grow to $6.43 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to growth in portable emergency devices, advancements in thoracic vent systems, increased ICU admissions, demand for faster lung re-expansion, emergency medical service expansion. Major trends in the forecast period include rapid emergency lung decompression, portable pneumothorax management devices, minimally invasive chest drainage, improved air leak control systems, simplified bedside treatment kits.
The rising number of respiratory diseases is anticipated to drive the growth of the pneumothorax treatment devices market. Respiratory diseases are conditions that affect the lungs and airways, leading to impaired breathing and reduced oxygen exchange. The increase in respiratory diseases is attributed to factors such as air pollution, smoking, viral infections, and greater exposure to allergens. Pneumothorax treatment devices are used in the management of respiratory conditions to treat collapsed lungs and restore normal respiratory function. For example, in September 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, deaths involving influenza rose from 611 in 2023 to 806 in 2024 and further increased to 1,057 deaths in the year to August 2025, representing a 73% rise compared with the same period in 2023. Additionally, deaths involving respiratory syncytial virus (RSV) increased from 380 in 2023 to 468 in 2024 and reached 399 deaths in the year to August 2025. Therefore, the growing incidence of respiratory diseases is driving the expansion of the pneumothorax treatment devices market.
Leading companies in the pneumothorax treatment devices market are focusing on developing advanced technological solutions, such as chest X-ray systems, to maintain their market position. Chest X-ray solutions involve imaging systems and technologies designed to capture detailed radiographic images of the chest, including the lungs, heart, ribs, and surrounding structures. For instance, in September 2023, Qure.ai, a US-based health tech company, announced that it received 510(k) FDA clearance for its innovative chest X-ray solution, qXR-PTX-PE. This solution is specifically designed to aid in the rapid detection of pneumothorax (PTX) and pleural effusion (PE). The AI-powered software enhances care in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare providers. The qXR-PTX-PE solution analyzes chest X-ray images for critical findings, significantly improving triage efficiency in emergency settings, where these conditions can pose serious risks to patient health.
In June 2023, Merit Medical Systems, Inc., a US-based medical technology company specializing in interventional, diagnostic, and critical care products, acquired AngioDynamics, Inc., for US$100 million in cash. Through this acquisition, Merit Medical aims to reinforce and expand its interventional oncology and lung biopsy-related complication management portfolio by incorporating the BioSentry system, which is designed to reduce the incidence of biopsy-related pneumothorax. This move is intended to strengthen Merit Medical’s position in the global pneumothorax treatment devices market while also broadening its offerings in vascular access and dialysis care. AngioDynamics, Inc. is a US-based medical device company focused on minimally invasive vascular, oncology, and biopsy-related products.
Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc.
North America was the largest region in the pneumothorax treatment devices market in 2025. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pneumothorax treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pneumothorax treatment devices market by increasing costs of imported ventilator components, chest drainage systems, and disposable kits. Ventilator devices and thoracic vent segments are most affected, particularly in North America and Europe due to reliance on Asia-Pacific manufacturing. While tariffs have raised procurement costs, they have also encouraged local manufacturing, simplified device designs, and regional sourcing strategies.
The pneumothorax treatment devices market research report is one of a series of new reports that provides pneumothorax treatment devices market statistics, including pneumothorax treatment devices industry global market size, regional shares, competitors with a pneumothorax treatment devices market share, detailed pneumothorax treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the pneumothorax treatment devices industry. This pneumothorax treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pneumothorax treatment devices are medical tools used to manage and treat a collapsed lung, a condition in which air accumulates in the pleural space. These devices aim to remove excess air, restore lung expansion, and prevent further complications, often through methods such as needle decompression or chest tube insertion.
The primary types of pneumothorax treatment devices include ventilator devices, thoracic vent devices, and others. Ventilator devices used in pneumothorax treatment help assist or control breathing by delivering air to the lungs, thereby maintaining oxygen levels and preventing further lung collapse during recovery. These devices are employed in various situations, such as traumatic pneumothorax, spontaneous pneumothorax, and others, in settings such as hospitals, ambulatory surgical centers, and other medical facilities.
The pneumothorax treatment devices market consists of sales of products including tubes, valves, suction devices and systems, and digital thoracic drainage systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pneumothorax Treatment Devices Market Characteristics
3. Pneumothorax Treatment Devices Market Supply Chain Analysis
4. Global Pneumothorax Treatment Devices Market Trends and Strategies
5. Pneumothorax Treatment Devices Market Analysis of End Use Industries
7. Global Pneumothorax Treatment Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pneumothorax Treatment Devices Total Addressable Market (TAM) Analysis for the Market
9. Pneumothorax Treatment Devices Market Segmentation
10. Pneumothorax Treatment Devices Market Regional and Country Analysis
11. Asia-Pacific Pneumothorax Treatment Devices Market
12. China Pneumothorax Treatment Devices Market
13. India Pneumothorax Treatment Devices Market
14. Japan Pneumothorax Treatment Devices Market
15. Australia Pneumothorax Treatment Devices Market
16. Indonesia Pneumothorax Treatment Devices Market
17. South Korea Pneumothorax Treatment Devices Market
18. Taiwan Pneumothorax Treatment Devices Market
19. South East Asia Pneumothorax Treatment Devices Market
20. Western Europe Pneumothorax Treatment Devices Market
21. UK Pneumothorax Treatment Devices Market
22. Germany Pneumothorax Treatment Devices Market
23. France Pneumothorax Treatment Devices Market
24. Italy Pneumothorax Treatment Devices Market
25. Spain Pneumothorax Treatment Devices Market
26. Eastern Europe Pneumothorax Treatment Devices Market
27. Russia Pneumothorax Treatment Devices Market
28. North America Pneumothorax Treatment Devices Market
29. USA Pneumothorax Treatment Devices Market
30. Canada Pneumothorax Treatment Devices Market
31. South America Pneumothorax Treatment Devices Market
32. Brazil Pneumothorax Treatment Devices Market
33. Middle East Pneumothorax Treatment Devices Market
34. Africa Pneumothorax Treatment Devices Market
36. Pneumothorax Treatment Devices Market Competitive Landscape and Company Profiles
37. Pneumothorax Treatment Devices Market Other Major and Innovative Companies
40. Pneumothorax Treatment Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pneumothorax Treatment Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pneumothorax treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pneumothorax treatment devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pneumothorax treatment devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Ventilator Devices; Thoracic Vent Devices; Other Types2) By Application: Traumatic Pneumothorax; Spontaneous Pneumothorax; Other Applications
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Ventilator Devices: Portable Ventilators; Non-Invasive Ventilators; Invasive Ventilators2) By Thoracic Vent Devices: Chest Drainage Systems; Heimlich Valves; One-Way Chest Valve Systems
3) By Other Types: Needle Aspiration Devices; Pleural Catheters; Oxygen Therapy Devices
Companies Mentioned: Cardinal Health Inc.; Medtronic PLC; Siemens Healthineers AG; Medline Industries Inc.; Fujifilm Holdings Corporation; Becton Dickinson and Company (BD); GE HealthCare Technologies Inc.; Stryker Corporation; Boston Scientific Corporation; Draegerwerk AG & Co. KGaA; Cook Medical Inc.; B. Braun Melsungen AG; Utah Medical Products Inc.; Rocket Medical plc; Nobelpharma Co. Ltd.; Sinapi Biomedical Inc.; UreSil Inc.; ATMOS MedizinTechnik GmbH & Co. KG; Betaglue Technologies S.p.A.; Selio Medical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pneumothorax Treatment Devices market report include:- Cardinal Health Inc.
- Medtronic PLC
- Siemens Healthineers AG
- Medline Industries Inc.
- Fujifilm Holdings Corporation
- Becton Dickinson and Company (BD)
- GE HealthCare Technologies Inc.
- Stryker Corporation
- Boston Scientific Corporation
- Draegerwerk AG & Co. KGaA
- Cook Medical Inc.
- B. Braun Melsungen AG
- Utah Medical Products Inc.
- Rocket Medical plc
- Nobelpharma Co. Ltd.
- Sinapi Biomedical Inc.
- UreSil Inc.
- ATMOS MedizinTechnik GmbH & Co. KG
- Betaglue Technologies S.p.A.
- Selio Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.39 Billion |
| Forecasted Market Value ( USD | $ 6.43 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
